Showing results (1-10 of 127) with videos related to
Sort By:
Pageof 13
Drug Design, Development and Therapy|July 31, 2014
Profile and potential of ixabepilone in the treatment of pancreatic cancerBrandon G Smaglo, Michael J PishvaianCancer Journal (Sudbury, Mass.)|November 29, 2012
Postresection chemotherapy for pancreatic cancerBrandon G Smaglo, Michael J PishvaianCancers|May 16, 2023
Role for Neoadjuvant Systemic Therapy for Potentially Resectable Pancreatic CancerBrandon G SmagloJournal of Gastrointestinal Oncology|September 3, 2013
Continuum of care with anti-angiogenic therapies in metastatic colorectal cancerBrandon G Smaglo, Jimmy HwangClinical Advances in Hematology & Oncology : H&O|April 9, 2016
Approach to the medical management of surgically resectable gastric cancerAnteneh Tesfaye, John L Marshall, Brandon G SmagloNature Reviews. Clinical Oncology|October 1, 2014
The development of immunoconjugates for targeted cancer therapyBrandon G Smaglo, Dalal Aldeghaither, Louis M WeinerJournal of Clinical Pharmacology|February 25, 2015
Beyond peptides and mAbs--current status and future perspectives for biotherapeutics with novel constructsDalal AlDeghaither, Brandon G Smaglo, Louis M WeinerClinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 17, 2020
A Phase I/II Study of Veliparib (ABT-888) in Combination with 5-Fluorouracil and Oxaliplatin in Patients with Metastatic Pancreatic CancerMichael J Pishvaian, Hongkun Wang, Aiwu Ruth He, et al.Oncology (Williston Park, N.Y.)|January 22, 2016
Neoadjuvant Treatment for Surgically Resectable Metastatic Colorectal CancerMarwan Al-Hajeili, John L Marshall, Brandon G SmagloSeminars in Radiation Oncology|September 11, 2025
Driving Precision Medicine in Pancreatic Cancer With Molecular GeneticsMaria Farooq, Michael J PishvaianPageof 13